Tiotropium Respimat® 2.5microgram solution for inhalation
Tiotropium 2.5 micrograms (Spiriva Respimat) is recommended as add-on maintenance bronchodilator treatment in adult patients with asthma who meet all of the following criteria:
• persistent airflow limitation demonstrated by a FEV1 80% predicted and a ratio of FEV1/FVC 70% and
• currently treated with the maintenance combination of inhaled corticosteroids (≥ 800 micrograms budesonide/day or equivalent*) and long-acting β2 agonists and
• experienced one or more severe exacerbations in the previous year.
Amber level 0
Reason for decision:
Suitable for GP prescribing following recommendation/initiation by specialist